Skip to content

comparing mesotherapy and minoxidil 5 % solution for male pattern baldness by using dermoscopy

â??Comparative Study between Mesotherapy with Hair Solution (Intralesional Injection) and Topical 5% Minoxidil by Dermoscopic Evaluation for Androgenic Alopecia in Male- A Randomized Controlled Trial.â??

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007740
Enrollment
70
Registered
2017-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- androgenic alopecia grade 2 to 5

Interventions

Intervention1: mesotherapy with microneedling: microneedling procedure with dermaroller on the scalp followed by intradermal injection of meso hair solution Control Intervention1: minoxidil 5 percent:

Sponsors

Department of Dermatology Venereology And Leprosy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Male between 18 to 35 years of age 2 grade 2 to 5 of androgenic alopecia according to Hamilton Norwood classification . 3 Those who have not applied topical minoxidil or Finasteride or oral Finasteride or have not undergone any procedure before 6 months. Those with diffuse hairloss for unknown reason other than Thyroid abnormality Malnutrition Chronic major illness, Anaemia

Exclusion criteria

Exclusion criteria: Males having less than 18 years of age. Past history of Hypersensitivity to any of the products of Meso hair solution. History of bleeding tendency or patient on antiplatelet or anticoagulant drugs. Thromboembolism Thyroid disorder Malnutrition Anaemia Past history of major illness like stroke cancer cardiovascular disease renal disease Insulin dependent Diabetes Mellitus before 6 months Patients having other dermatological disorder which leads to hairloss like SLE psoriasis Pemphigus vulgaris Patient not willing to participate in the study Immunocompromised Patient having infective focus in other body parts

Design outcomes

Primary

MeasureTime frame
number of white dots black dots and yellow dots variation in hair shaft diameter proportion of terminal to vellous hairs total hair density amount new hair growth based on dermoscopy and trichoscanTimepoint: 0 month 1 month 2nd month 3rd month 4th month

Secondary

MeasureTime frame
7 point assessment scale patient self satisfaction score clinical photographsTimepoint: 0 month 1 month 2nd month 3rd month 4th month

Countries

India

Contacts

Public ContactDr Hita Mehta

Government Medical college Bhavnagar

hitamehta88@gmail.com9429503188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026